MayTech Global Investments LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 162,852 shares of the medical device company’s stock after purchasing an additional 1,151 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) CFO Jereme M. Sylvain sold 745 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $115.05, for a total transaction of $85,712.25. Following the completion of the transaction, the chief financial officer now owns 84,948 shares […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Sadie Stern sold 427 shares of DexCom stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $115.05, for a total transaction of $49,126.35. Following the sale, the executive vice president now directly owns 75,877 shares of the […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Sadie Stern sold 427 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $115.05, for a total transaction of $49,126.35. Following the completion of the sale, the executive vice president now directly owns 75,877 shares in […]
Abbott Laboratories received U.S. FDA clearance for its Lingo and Libre Rio over-the-counter continuous glucose monitoring systems, enabling it to challenge Dexcom Inc. in this rapidly growing market. Dexcom received FDA clearance for its OTC Stela continuous glucose monitor in March.